Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Enliven Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- +1 vs. Q3 2023
- Shares held
- 39.0M
- −75.9K (−0.2%) vs. Q3 2023
- Total value
- $539.8M
- +$6.01M (+1.1%) vs. Q3 2023
- New holders
- 8
- 23 more added
- Sold out
- 7
- 13 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Covestor Ltd | 1 | $0 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 5 | $69 | 0.00% | +5 | New |
| Farther Finance Advisors, LLC | 6 | $83 | 0.00% | +6 | New |
| Nisa Investment Advisors, LLC | 9 | $125 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 12 | $166 | 0.00% | +12 | New |
| GAMMA Investing LLC | 37 | $581 | 0.00% | +37 | New |
| Baystate Wealth Management LLC | 50 | $692 | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,279 | $17.7K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,928 | $26.7K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $27.7K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,036 | $28.0K | 0.00% | −234−10.3% | Reduced |
| AJOVista, LLC | 2,046 | $28.3K | 0.04% | +2,046 | New |
| China Universal Asset Management Co., Ltd. | 4,763 | $65.9K | 0.01% | +4,763 | New |
| Tower Research Capital LLC (TRC) | 5,485 | $75.9K | 0.00% | −1,270−18.8% | Reduced |
| Wells Fargo & Company | 7,158 | $99.1K | 0.00% | +1,418+24.7% | Added |
| Citigroup Inc | 7,406 | $102.5K | 0.00% | +4,059+121.3% | Added |
| Royal Bank of Canada | 7,991 | $110.0K | 0.00% | +3,284+69.8% | Added |
| Exchange Traded Concepts, LLC | 8,708 | $120.5K | 0.00% | +2,208+34.0% | Added |
| New York State Common Retirement Fund | 9,399 | $130.1K | 0.00% | −54−0.6% | Reduced |
| Manufacturers Life Insurance Company, The | 10,095 | $139.7K | 0.00% | +10,095 | New |
| Deutsche Bank AG | 10,631 | $147.1K | 0.00% | −259−2.4% | Reduced |
| American International Group, Inc. | 11,603 | $160.6K | 0.00% | −46−0.4% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 12,305 | $170.3K | 0.00% | +1,029+9.1% | Added |
| MetLife Investment Management | 12,345 | $170.9K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 12,488 | $172.8K | 0.00% | −6,278−33.5% | Reduced |
| SG Americas Securities, LLC | 13,501 | $187.0K | 0.00% | +2,041+17.8% | Added |
| Alliancebernstein L.P. | 14,970 | $207.2K | 0.00% | +640+4.5% | Added |
| Jane Street Group, LLC | 15,684 | $217.1K | 0.00% | +15,684 | New |
| State of Wisconsin Investment Board | 18,241 | $252.5K | 0.00% | −707−3.7% | Reduced |
| Legal & General Group Plc | 19,665 | $272.2K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 20,330 | $281.4K | 0.00% | −1,179−5.5% | Reduced |
| Credit Suisse AG | 21,895 | $303.0K | 0.00% | −955−4.2% | Reduced |
| Goldman Sachs Group Inc | 22,698 | $314.1K | 0.00% | +5,008+28.3% | Added |
| JPMorgan Chase & Co | 23,989 | $332.0K | 0.00% | −2,506−9.5% | Reduced |
| Bank of America Corp | 30,727 | $425.3K | 0.00% | +7,621+33.0% | Added |
| Swiss National Bank | 36,473 | $504.8K | 0.00% | −4,200−10.3% | Reduced |
| Rhumbline Advisers | 37,343 | $516.8K | 0.00% | +2,980+8.7% | Added |
| Barclays PLC | 42,078 | $582.4K | 0.00% | +28,449+208.7% | Added |
| BML Capital Management, LLC | 50,000 | $692.0K | 0.55% | 00.0% | Unchanged |
| Morgan Stanley | 79,521 | $1.10M | 0.00% | +45,551+134.1% | Added |
| Bank of New York Mellon Corp | 80,129 | $1.11M | 0.00% | −630−0.8% | Reduced |
| Nuveen Asset Management, LLC | 86,629 | $1.20M | 0.00% | −338−0.4% | Reduced |
| Acuta Capital Partners, LLC | 123,876 | $1.71M | 0.97% | +20,276+19.6% | Added |
| HighVista Strategies LLC | 137,241 | $1.90M | 0.69% | +12,654+10.2% | Added |
| Charles Schwab Investment Management Inc | 158,440 | $2.19M | 0.00% | +1,809+1.2% | Added |
| Northern Trust Corp | 224,812 | $3.11M | 0.00% | +30,278+15.6% | Added |
| Logos Global Management LP | 307,076 | $4.25M | 0.47% | 00.0% | Unchanged |
| Woodline Partners LP | 395,686 | $5.48M | 0.06% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 408,514 | $5.68M | 0.00% | +132,098+47.8% | Added |
| Geode Capital Management, LLC | 464,657 | $6.43M | 0.00% | +31,685+7.3% | Added |
| State Street Corp | 484,515 | $6.71M | 0.00% | +13,663+2.9% | Added |
| Boxer Capital, LLC | 646,058 | $8.94M | 0.45% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,230,888 | $17.0M | 0.00% | +79,071+6.9% | Added |
| BlackRock Inc. | 1,849,658 | $25.6M | 0.00% | +282,126+18.0% | Added |
| Ra Capital Management, L.P. | 2,122,465 | $29.4M | 0.46% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,131,369 | $29.5M | 3.12% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,394,448 | $33.1M | 0.03% | +42,957+1.8% | Added |
| Commodore Capital LP | 2,901,816 | $40.2M | 3.51% | 00.0% | Unchanged |
| VR Adviser, LLC | 2,954,902 | $40.9M | 2.80% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 5,160,975 | $71.4M | 18.95% | 00.0% | Unchanged |
| FMR LLC | 5,161,242 | $71.4M | 0.01% | +1,485,029+40.4% | Added |
| OrbiMed Advisors LLC | 8,998,338 | $124.5M | 2.49% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,216,712−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,050,483−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −27,006−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −17,950−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −12,972−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −566−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −105−100.0% | Sold out |